Midodrine hydrochloride
NDC 68382-737, Midodrine hydrochloride, tablet, from Zydus Pharmaceuticals (USA) Inc..
- Product NDC
- 68382-737
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213055
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68382-737 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MIDODRINE HYDROCHLORIDE2.5 mg/1
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68382-737-01 | 68382073701 | 100 TABLET in 1 BOTTLE (68382-737-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3bc97210-fa2f-4979-abdf-d92e5973e6e3NADAC price for package 68382073701
GET /v1/drugs/nadac/68382073701
Use it
Look up 68382-737 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68382-737 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68382-737. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.